| PERIOD ENDING | 30-Sep-09 | 27-Jun-09 | 28-Mar-09 | 31-Dec-08 | | Total Revenue | 167,415 | 160,125 | 146,763 | 182,836 | | Cost of Revenue | 94,729 | 92,569 | 96,252 | 121,971 | | | Gross Profit | 72,686 | 67,556 | 50,511 | 60,865 | | | Operating Expenses | | Research Development | 15,179 | 15,079 | 14,852 | 18,664 | | Selling General and Administrative | 37,439 | 37,482 | 36,256 | 43,202 | | Non Recurring | 26,051 | 597 | 10,791 | 118,512 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,983) | 14,398 | (11,388) | (119,513) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 884 | 1,347 |
-
|
-
| | Earnings Before Interest And Taxes | (5,099) | 15,745 | (11,388) | (119,513) | | Interest Expense |
-
|
-
| 415 | 1,499 | | Income Before Tax | (5,099) | 15,745 | (11,803) | (121,012) | | Income Tax Expense | (4,353) | 5,095 | (771) | (29,003) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (746) | 10,650 | (11,032) | (92,009) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (746) | 10,650 | (11,032) | (92,009) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($746) | $10,650 | ($11,032) | ($92,009) |
|
1.48% Nasdaq 
Income Statement
